Decentralized/POC Coagulation Testing Market- Identify Key Business Opportunities 2017 - 2025
Cardiovascular diseases present a wide range of blood disorders (haemostasis) that influences the development cardiovascular co morbidities. Patients exhibiting such symptoms are often prescribed on anti-thrombotic medications to prevent the onset of adverse cardiovascular events arising as a result of the sudden rise in blood coagulation factors. In addition, patients undergoing cardiovascular surgery also present haemostatic disorders along with their existing disease state besides their adjunctive medication or the presence of any coagulation disturbances induced by a cardiopulmonary bypass surgery....
View full press release